Damase-Michel C, Tran M A, Llau M E, Chollet F, Senard J M, Guiraud-Chaumeil B, Montastruc J L, Montastruc P
Laboratoire de Pharmacologie Médicale et Clinique, INSERM, Toulouse, France.
Eur J Clin Pharmacol. 1993;44(2):199-201. doi: 10.1007/BF00315481.
We have studied the sympathetic response to blockade of presynaptic alpha 2-adrenoceptors in essential hypertension by measuring plasma concentrations of noradrenaline after a single oral dose of yohimbine, an alpha 2-adrenoceptor antagonist. Mean baseline plasma noradrenaline and adrenaline concentrations were similar in the hypertensive and normotensive groups. Yohimbine (0.2 mg x kg-1 orally) caused a lesser increase in the plasma concentrations of noradrenaline in hypertensive patients (+67%) than in normotensive subjects (+178%) and a pressor response in hypertensive (but not in normotensive) patients. These results are consistent with an alteration in the balance of alpha-adrenoceptors (for example presynaptic alpha 2-adrenoceptor desensitization and post-synaptic alpha 1-adrenoceptor hyper-responsiveness) which would help to develop and/or maintain arterial hypertension.
我们通过单次口服α2肾上腺素能受体拮抗剂育亨宾后测量去甲肾上腺素的血浆浓度,研究了原发性高血压患者对突触前α2肾上腺素能受体阻断的交感反应。高血压组和正常血压组的平均基线血浆去甲肾上腺素和肾上腺素浓度相似。育亨宾(0.2mg·kg-1口服)使高血压患者血浆去甲肾上腺素浓度的升高幅度(+67%)小于正常血压受试者(+178%),且在高血压患者中引起升压反应(正常血压患者无此反应)。这些结果与α肾上腺素能受体平衡的改变(例如突触前α2肾上腺素能受体脱敏和突触后α1肾上腺素能受体反应性过高)一致,这有助于发展和/或维持动脉高血压。